Sugi Predict

Sugi Predict / Compounds / SCHEMBL112708

SCHEMBL112708

SCHEMBL112708

CCCCOc1ccccc1N

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 2/20 1.00
▸ CYP2C9 P11712 2/20 1.00
▸ CYP2C19 P33261 2/20 1.00
▸ ALDH1A1 P00352 5/20 0.67
▸ MCHR1 Q99705 3/20 0.51
▸ TLR8 Q9NR97 3/20 0.51
▸ HSD17B10 Q99714 1/20 0.50
▸ ADRA2B P18089 1/20 0.50
▸ PTGS1 P23219 1/20 0.50
▸ TDP1 Q9NUW8 1/20 0.50
▸ MEN1 O00255 2/20 0.49
▸ MAPT P10636 2/20 0.49
▸ KMT2A Q03164 2/20 0.49
▸ LMNA P02545 2/20 0.49
▸ NR1I2 O75469 1/20 0.49
▸ CHRM2 P08172 1/20 0.49
▸ CYP3A4 P08684 1/20 0.49
▸ ADRA2A P08913 1/20 0.49
▸ OPRK1 P41145 1/20 0.49
▸ HTR2B P41595 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1341248 0.94 CYP1A2 (0.89) CYP1A2CYP2C9CYP2C19ALDH1A1MCHR1
SCHEMBL905671 0.92 CYP1A2 (0.85) CYP1A2CYP2C9CYP2C19ALDH1A1MCHR1
SCHEMBL21694180 0.92 CYP1A2 (0.85) CYP1A2CYP2C9CYP2C19ALDH1A1MCHR1
SCHEMBL3523843 0.92 CYP1A2 (0.85) CYP1A2CYP2C9CYP2C19ALDH1A1MCHR1
SCHEMBL10430130 0.92 CYP1A2 (0.85) CYP1A2CYP2C9CYP2C19ALDH1A1MCHR1
SCHEMBL4950279 0.92 CYP1A2 (0.85) CYP1A2CYP2C9CYP2C19ALDH1A1MCHR1
SCHEMBL10408892 0.92 CYP1A2 (0.85) CYP1A2CYP2C9CYP2C19ALDH1A1MCHR1
SCHEMBL18049454 0.92 CYP1A2 (0.85) CYP1A2CYP2C9CYP2C19ALDH1A1MCHR1
SCHEMBL8389395 0.92 CYP1A2 (0.85) CYP1A2CYP2C9CYP2C19ALDH1A1MCHR1
SCHEMBL5085710 0.92 CYP1A2 (0.85) CYP1A2CYP2C9CYP2C19ALDH1A1MCHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 213 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114853794-B Preparation method of polycyclic aromatic hydrocarbon with pyrrole and boron-nitrogen units embedded into perylene 内蒙古大学 2024-02-23 — — CN claimed
CN-115362535-A UV curable resin composition suitable for redistribution layers 设计分子有限公司 2022-11-18 — — CN claimed
EP-0782151-B1 Method of manufacturing an improved electrically conductive polymer, its use in the manufacture of electric cable and cable manufactured by this method NEXANS (FR) 2002-02-13 — — EP claimed
EP-0828345-A1 Electrical conductor protected against electromagnetic disturbances exceeding a threshold Alcatel Cable France (FR) 1998-03-11 — — EP claimed
EP-0782151-A1 Method of manufacturing an improved electrically conductive polymer, its use in the manufacture of electric cable and cable manufactured by this method ALCATEL (FR) 1997-07-02 — — EP claimed
US-5035970-A Encapsulated toner compositions and processes thereof XEROX CORPORATION (US) 1991-07-30 — — US claimed
WO-2026047441-A1 ADHESIVE COMPOSITION COMPRISING MALEIMIDE MOIETIES AND METHODS OF WET ETCHING 3M INNOVATIVE PROPERTIES COMPANY (US) 2026-03-05 — — WO disclosed
CN-116018381-B Polarizing film, polarizing plate and liquid crystal display device containing azo compound or salt thereof 日本化药株式会社 2025-05-02 — — CN disclosed
CN-119677819-A Azo compound or salt thereof, and polarizing film, polarizing plate and liquid crystal display device each containing the same 日本化药株式会社 2025-03-21 — — CN disclosed
US-20240294465-A1 NOVEL ANTI-FIBROTIC DRUGS HELMHOLTZ ZENTRUM MÜNCHEN - DEUTSCHES FORSCHUNGSZENTRUM FÜR GESUNDHEIT UND UMWELT (DE) 2024-09-05 — — US disclosed
CN-114945636-B Azo compound or salt thereof, polarizing film, polarizing plate, and display device 日本化药株式会社 2024-07-12 — — CN disclosed
US-20240231230-A1 COMPOSITION FOR FORMING SILICON-CONTAINING RESIST UNDERLAYER FILM NISSAN CHEMICAL CORPORATION (JP) 2024-07-11 — — US disclosed
CN-114008143-B Azo compound, polarizing film containing the same, and polarizing plate 日本化药株式会社 2024-05-14 — — CN disclosed
US-4204002-A FOR COMBATTING PHYTOPATHOGENIC FUNGI CIBA-GEIGY CORPORATION (US) 1980-05-20 — — US disclosed
US-4178167-A Herbicidal N-(haloacetyl)-N-(N'-methylenepyrrolidonyl)-2-alkoxyanilines useful as herbicides GAF CORPORATION (US) 1979-12-11 — — US disclosed
US-4150019-A COLORFAST, HEAT RESISTANT, MIGRATION HOECHST AKTIENGESELLSCHAFT (DE) 1979-04-17 — — US disclosed
US-4093738-A FUNGICIDES CIBA-GEIGY CORPORATION (US) 1978-06-06 — — US disclosed
US-4039690-A CONTROL OF NITROSAMINE FORMATION IN NITRITE CURED MEAT BY USE OF AROMATIC PRIMARY AMINES CANADA PACKERS LIMITED (CA) 1977-08-02 — — US disclosed
US-3981717-A ANILINO COMPOUNDS AMERICAN CYANAMID COMPANY (US) 1976-09-21 — — US disclosed
US-3954997-A MITICIDES, INSECTICIDES THE UPJOHN COMPANY (US) 1976-05-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240294465-A1 NOVEL ANTI-FIBROTIC DRUGS FAH, ACAT2, FIBP CYP1A2 927/4885CYP2C9 1533/4885CYP2C19 1593/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.